Jane Street Group, LLC Bio N Tech Se Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Jane Street Group, LLC holds 41,130 shares of BNTX stock, worth $5.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,130
Previous 57,183 28.07%
Holding current value
$5.09 Million
Previous $4.6 Million 6.31%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$78.36 - $124.66 $1.26 Million - $2 Million
-16,053 Reduced 28.07%
41,130 $4.89 Million
Q2 2024

Aug 14, 2024
SELL
$80.36 - $102.87 $3 Million - $3.83 Million
-37,275 Reduced 39.46%
57,183 $4.6 Million
Q1 2024

May 15, 2024
SELL
$88.96 - $112.35 $1.38 Million - $1.74 Million
-15,502 Reduced 14.1%
94,458 $8.71 Million
Q4 2023

Feb 14, 2024
BUY
$90.91 - $112.75 $5.99 Million - $7.43 Million
65,882 Added 149.47%
109,960 $11.6 Million
Q3 2023

Nov 14, 2023
SELL
$98.5 - $125.08 $2.64 Million - $3.35 Million
-26,792 Reduced 37.8%
44,078 $4.79 Million
Q2 2023

Aug 14, 2023
SELL
$102.58 - $129.66 $795,097 - $1 Million
-7,751 Reduced 9.86%
70,870 $7.65 Million
Q1 2023

May 15, 2023
BUY
$122.57 - $153.67 $1.55 Million - $1.94 Million
12,608 Added 19.1%
78,621 $9.79 Million
Q4 2022

Feb 14, 2023
BUY
$118.43 - $186.05 $4.72 Million - $7.42 Million
39,878 Added 152.58%
66,013 $9.92 Million
Q3 2022

Nov 14, 2022
SELL
$127.65 - $183.11 $10.2 Million - $14.6 Million
-79,926 Reduced 75.36%
26,135 $3.53 Million
Q2 2022

Aug 16, 2022
SELL
$123.25 - $186.24 $2.25 Million - $3.4 Million
-18,279 Reduced 14.7%
106,061 $15.8 Million
Q1 2022

May 17, 2022
SELL
$126.25 - $231.85 $15.7 Million - $28.9 Million
-124,719 Reduced 50.08%
124,340 $21.2 Million
Q4 2021

Feb 15, 2022
BUY
$216.64 - $362.52 $27.7 Million - $46.3 Million
127,661 Added 105.16%
249,059 $64.2 Million
Q3 2021

Nov 16, 2021
BUY
$205.93 - $447.23 $11.3 Million - $24.5 Million
54,878 Added 82.5%
121,398 $33.1 Million
Q2 2021

Aug 16, 2021
SELL
$113.32 - $241.49 $1.96 Million - $4.18 Million
-17,289 Reduced 20.63%
66,520 $14.9 Million
Q1 2021

May 18, 2021
SELL
$85.73 - $119.5 $16.8 Million - $23.5 Million
-196,367 Reduced 70.09%
83,809 $9.15 Million
Q4 2020

Feb 17, 2021
BUY
$72.71 - $129.54 $10.1 Million - $18 Million
138,786 Added 98.16%
280,176 $22.8 Million
Q3 2020

Nov 17, 2020
BUY
$57.81 - $104.17 $5.42 Million - $9.77 Million
93,827 Added 197.27%
141,390 $9.7 Million
Q2 2020

Aug 17, 2020
BUY
$38.58 - $66.74 $1.32 Million - $2.29 Million
34,314 Added 258.99%
47,563 $3.19 Million
Q1 2020

May 15, 2020
BUY
$28.55 - $92.0 $378,258 - $1.22 Million
13,249 New
13,249 $774,000

Others Institutions Holding BNTX

# of Institutions
360
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $30B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email